[1]
Aisha Alyassi, “META-ANALYSIS OF CARDIOPROTECTIVE EFFECTS OF COMBINED SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS VS. MONOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE: IMPACT ON MORTALITY AND HOSPITALIZATION OUTCOMES”, IJHR, vol. 2, no. 2 (Health & Rehab), pp. 176–186, Nov. 2024, doi: 10.71000/ijhr139.